Overview
Portfolio
More
Pier70 Ventures
Seattle, United States
Impact‑driven healthcare focus, backing disruptive technologies and diverse teams.
Portfolio
3+
Employees
15+
Founded
2017
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
North America
Sources
Pier70 Ventures
Impact‑driven healthcare focus, backing disruptive technologies and diverse teams.
Portfolio
3+
Employees
15+
Founded
2017
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
North America
Sources
Showing 3 of 3 matched portfolio companies
DermaSensor provides an FDA Cleared, handheld device that uses optical spectroscopy and proprietary AI algorithms to non-invasively assess suspicious skin lesions. This technology delivers instant risk assessment outputs to aid healthcare providers in making objective referral decisions for melanoma, basal cell carcinoma, and squamous cell carcinoma. The system enhances clinical confidence by offering rapid, objective data to supplement traditional visual assessment at the point of care.
MedHaul is a centralized transportation platform that connects healthcare organizations with a network of non-emergency medical transportation providers, automating the scheduling and tracking of rides for patients with unique mobility needs. The service addresses the issue of missed healthcare appointments by ensuring reliable and safe transportation for vulnerable communities, including those requiring wheelchair and stretcher transport.
Funding: $7.2M
Rough estimate of the amount of funding raised
Funding: $7.2M
Rough estimate of the amount of funding raised
Movn Health provides a telehealth platform for remote cardiac rehabilitation and cardiovascular prevention, utilizing a mobile app and remote monitoring care kit developed in collaboration with Stanford University. The service addresses the lack of access to traditional cardiac rehab programs, offering personalized, evidence-based care that improves patient outcomes and reduces hospital readmissions.
Funding: $20.0M
Rough estimate of the amount of funding raised
Funding: $20.0M
Rough estimate of the amount of funding raised